Viewing Study NCT00977067


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-01-25 @ 8:49 AM
Study NCT ID: NCT00977067
Status: TERMINATED
Last Update Posted: 2017-06-21
First Post: 2009-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module